Containing Nucleic Acid Patents (Class 977/804)
  • Patent number: 11905524
    Abstract: Provided herein are compositions and methods for packaging a recombinant adeno-associated vims (rAAV) particle comprising using inverted terminal repeats (ITRs) and rep genes of different serotypes and/or using chimeric rep genes.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: February 20, 2024
    Assignee: University of Florida Research Foundation, Incorporated
    Inventors: Mavis Agbandje-McKenna, Mario Mietzsch, Robert McKenna
  • Patent number: 11883476
    Abstract: The present invention provides a vaccine for canine Lyme disease and methods of making and using the vaccine alone, or in combinations with other protective agents.
    Type: Grant
    Filed: December 3, 2018
    Date of Patent: January 30, 2024
    Assignee: Intervet Inc.
    Inventors: Rhonda LaFleur, Jennifer C. Dant, Mark A. Mogler, Steven M. Callister, Zhichang Xu
  • Patent number: 11597946
    Abstract: Provided herein are compositions and methods for packaging a recombinant adeno-associated vims (rAAV) particle comprising using inverted terminal repeats (ITRs) and rep genes of different serotypes and/or using chimeric rep genes.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: March 7, 2023
    Assignee: University of Florida Research Foundation, Incorporated
    Inventors: Mavis Agbandje-McKenna, Mario Mietzsch, Robert McKenna
  • Patent number: 7329807
    Abstract: The present invention relates to novel fusogenic vesicles as highly efficient and versatile encapsulation systems for delivering a substance of choice, such as nucleic acids, proteins, peptides, antigens, pharmaceutical drugs and cosmetic agents to cells and tissues.
    Type: Grant
    Filed: November 21, 2003
    Date of Patent: February 12, 2008
    Assignee: Pevion Biotech Ltd.
    Inventors: Sonia Vadrucci, Joseph Brunner, Rinaldo Zurbriggen